World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
31972
World Ranking
10885
National Ranking
591

Overview

Jürgen Finke is affiliated with the University of Freiburg in Germany. Their body of research primarily centers on hematology, with significant contributions in related fields such as genetics, public health, oncology, and immunology. Their work is predominantly situated at the intersection of clinical and research medicine, focusing on conditions and treatments associated with hematopoietic stem cell transplantation and various forms of leukemia and lymphoma.

The scientist has published extensively within several specialized venues. The most frequent publication outlets include Bone Marrow Transplantation, Blood, Research Square, British Journal of Haematology, and the American Journal of Hematology. These publications reflect their engagement with peer-reviewed journals that emphasize blood diseases, transplantation, and hematological malignancies.

Their research topics cover a range of hematology-related subjects. Key areas include hematopoietic stem cell transplantation, acute myeloid leukemia research, acute lymphoblastic leukemia research, chronic myeloid leukemia treatments, myeloproliferative neoplasms diagnosis and treatment, CNS lymphoma diagnosis and treatment, and lymphoma diagnosis and treatment.

Frequent collaborators in these research endeavors are Nicolaus Kröger, Ibrahim Yakoub-Agha, Arnon Nagler, Mohamad Mohty, and Jakob Passweg. These colleagues share a high volume of joint publications, indicating established research partnerships and collaborative projects within the hematology and transplantation disciplines.

Among Jürgen Finke's recent scientific papers are the following:

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN), 2020, Journal of Clinical Oncology
  • Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial, 2022, Leukemia
  • Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel, 2020, Bone Marrow Transplantation
  • Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas, 2022, Journal of Clinical Oncology
  • Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia, 2021, Bone Marrow Transplantation

Best Publications

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).

    M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni

  • Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

    Andrés J M Ferreri;Kate Cwynarski;Elisa Pulczynski;Maurilio Ponzoni

  • Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    Andreas Burchert;Gesine Bug;Lea V. Fritz;Jürgen Finke

  • Antilymphocyte globulin for prevention of chronic graft-versus-host disease

    Nicolaus Kröger;Carlos Solano;Christine Wolschke;Giuseppe Bandini

  • Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R

    Konrad Wilhelm;Jayanthi Ganesan;Tobias Müller;Christoph Dürr

  • Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

    Rodrigo Martino;Simona Iacobelli;Ronald Brand;Thekla Jansen

  • Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.

    R.M. Weber-Nordt;C. Egen;J. Wehinger;W.D. Ludwig

  • Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

    Silvia Spoerl;Nimitha R. Mathew;Michael Bscheider;Annette Schmitt-Graeff

  • Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

    Olivier Hermine;Olivier Hermine;Eva Hoster;Jan Walewski;André Bosly

  • Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

    Pierre Reusser;Hermann Einsele;John Lee;Liisa Volin

  • Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

    Cristina Toffalori;Laura Zito;Valentina Gambacorta;Michela Riba

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

    Gérard Socié;Claudia Schmoor;Wolfgang A. Bethge;Hellmut D. Ottinger

  • Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

    Stephan Stilgenbauer;Thorsten Zenz;Dirk Winkler;Andreas Bühler

  • Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    Theo De Witte;David Bowen;Marie Robin;Luca Malcovati

  • Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

    ZiYi Lim;Ronald Brand;Rodrigo Martino;Anja van Biezen

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Myriam Labopin
Myriam Labopin Université Paris Cité
Robert Zeiser
Robert Zeiser University of Freiburg
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Jakob Passweg
Jakob Passweg University Hospital of Basel
Arnold Ganser
Arnold Ganser Hannover Medical School
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens doors to many related fields and flexible online study options. For registered nurses aiming to become family nurse practitioners, there are flexible asn to fnp bridge programs, allowing RNs to seamlessly transition toward advanced practice roles while balancing work and life.

Nutrition and wellness are growing sectors within healthcare. Aspiring nutritionists and dietitians can explore the best online nutrition programs to start or advance their careers, all from the convenience of home.

For future healthcare leaders, choosing a graduate program can be daunting. Learn how to evaluate healthcare administration degree programs to ensure the right fit, accreditation, and educational quality for your career goals.

Additionally, many nurses can further their credentials through rn to bsn online no clinicals accredited programs. These flexible, accredited programs eliminate the need for additional clinical rotations, making it easier to advance your education and job prospects.

Best Scientists Citing Jürgen Finke

Trending Scientists

Recently Published Articles